Regenxbio (RGNX) Revenue Growth (3y) (2017 - 2025)
Regenxbio (RGNX) Revenue Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - | - |
| 10 | Regenxbio | 506.19 Mn | 276.12 Mn | 21.22 Mn | -4.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.68% |
| Sep 30, 2025 | 3.90% |
| Jun 30, 2025 | -13.19% |
| Mar 31, 2025 | 57.65% |
| Dec 31, 2024 | -62.39% |
| Sep 30, 2024 | -7.70% |
| Jun 30, 2024 | -0.29% |
| Mar 31, 2024 | -6.69% |
| Dec 31, 2023 | 1.18% |
| Sep 30, 2023 | -33.63% |
| Jun 30, 2023 | 6.44% |
| Mar 31, 2023 | 2.75% |
| Dec 31, 2022 | 38.62% |
| Sep 30, 2022 | 21.72% |
| Jun 30, 2022 | 60.61% |
| Mar 31, 2022 | 192.92% |
| Dec 31, 2021 | 113.83% |
| Sep 30, 2021 | 79.67% |
| Jun 30, 2021 | -18.05% |
| Mar 31, 2021 | -47.75% |